Results 11 to 20 of about 4,257,669 (272)

ASSESSMENT OF SPECIATION AND ANTIFUNGAL SUSCEPTIBILITY TESTING IN THE INTENSIVE CARE UNIT: AN OBSERVATIONAL CROSS-SECTIONAL STUDY DESIGN.

open access: yesStudent's Journal of Health Research Africa, 2023
Objectives:  This study aims to investigate the epidemiology of Candidemia in patients admitted to Intensive Care Units (ICUs), focusing on the distribution of species, antifungal susceptibility patterns, and demographic factors.
Bhuvan Shome   +5 more
doaj   +1 more source

Rapid Antifungal Susceptibility Testing of Yeasts and Molds by MALDI-TOF MS: A Systematic Review and Meta-Analysis

open access: yesJournal of Fungi, 2021
Due to the growing burden of fungal infections and a recent rise in antifungal resistance, antifungal susceptibility testing (AFST) is of increasing importance.
Miriam Alisa Knoll   +2 more
doaj   +1 more source

Investigating the factors influencing RDX shock sensitivity [PDF]

open access: yes, 2012
The shock sensitivity of RDX (cyclotrimethylenetrinitramine) is dependent upon factors including crystal size, morphology, internal defects, surface defects and HMX content.
Hudson, R J
core   +7 more sources

Pharmacodynamic Effects of Simulated Standard Doses of Antifungal Drugs against Aspergillus Species in a New In Vitro Pharmacokinetic/Pharmacodynamic Model [PDF]

open access: yes, 2011
In conventional MIC tests, fungi are exposed to constant drug concentrations, whereas in vivo, fungi are exposed to changing drug concentrations.
Thomas J. Walsh   +11 more
core   +1 more source

Advanced approach for antifungal susceptibility and characterization of resistance properties in clinical and environmental isolates of Cryptococcus species complex

open access: yesInfectious Medicine, 2022
Background: Meningitis due to Cryptococcus neoformans/gattii is a fatal infection affecting immunocompromised population worldwide. Amphotericin B (AmB), fluconazole (FLC) and 5-flucytosine are the drugs of choice to treat the infection.
Shayanki Lahiri   +1 more
doaj   +1 more source

Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. [PDF]

open access: yes, 2013
Current, widely accepted guidelines for the management of HIV-associated cryptococcal meningoencephalitis (CM) recommend amphotericin B combined with flucytosine (5-FC) for ≥2 weeks as the initial induction treatment of choice.
A. Loyse   +10 more
core   +1 more source

A case of Candida famata sepsis in a very low birth weight infant successfully treated with fluconazole following antifungal susceptibility testing

open access: yesMedical Journal of Dr. D.Y. Patil University, 2015
Late onset of fungal sepsis in very low birth weight (VLBW) infants is common and has a high mortality and morbidity. Many of these infants were also receiving fluconazole prophylaxis.
Shilpee Raturi   +2 more
doaj   +1 more source

Use of volatile fingerprints for rapid screening of antifungal agents for efficacy against dermatophyte Trichophyton species [PDF]

open access: yes, 2010
The potential of using an electronic nose (E-nose) as a rapid technique for screening the responses of dermatophytes to antifungal agents was studied.
Adriaans, B   +9 more
core   +1 more source

Chemical Composition of Essential Oilsof Thymus and Mentha Speciesand Their Antifungal Activities [PDF]

open access: yes, 2009
The potential antifungal effects of Thymus vulgaris L., Thymus tosevii L., Mentha spicata L., and Mentha piperita L. (Labiatae) essential oils and their components against 17 micromycetal food poisoning, plant, animal and human pathogens are presented ...
Marin, P.D.   +31 more
core   +1 more source

First report of cryptococcuria in a bitch from India: a case report

open access: yesBulletin of the National Research Centre, 2020
Background Cryptococcuria has not been reported in dogs although few cases have been described in humans and cats. Cryptococcuria is often seen as a manifestation of systemic or disseminated cryptococcosis.
Abhishek Dharm Singh   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy